These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


530 related items for PubMed ID: 16309575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Statins: another class of antihypertensive agents?
    Milionis HJ, Liberopoulos EN, Achimastos A, Elisaf MS, Mikhailidis DP.
    J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure lowering only or more? Has the jury reached its verdict?
    Julius S.
    Am J Cardiol; 2007 Aug 06; 100(3A):32J-37J. PubMed ID: 17666196
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME, Jankowski P.
    Expert Opin Pharmacother; 2010 Nov 06; 11(16):2625-34. PubMed ID: 20977399
    [Abstract] [Full Text] [Related]

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 06; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 6. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?
    Minami J, Ishimitsu T, Matsuoka H.
    Am J Hypertens; 2008 Feb 06; 21(2):130-1; author reply 132. PubMed ID: 18268482
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF.
    Curr Opin Cardiol; 2006 Sep 06; 21(5):486-91. PubMed ID: 16900013
    [Abstract] [Full Text] [Related]

  • 8. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ, Anderson S.
    Pharmacotherapy; 2007 Sep 06; 27(9):1322-33. PubMed ID: 17723086
    [Abstract] [Full Text] [Related]

  • 9. Endothelin receptor antagonists as antihypertensives: the next frontier.
    Epstein BJ, Anderson S.
    Expert Rev Cardiovasc Ther; 2009 Jun 06; 7(6):675-87. PubMed ID: 19505283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 06; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition.
    Ferro A, Gilbert R, Krum H.
    Int J Clin Pract; 2006 May 06; 60(5):577-81. PubMed ID: 16700858
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The blood pressure measurement--revisited.
    Safar ME, Smulyan H.
    Am Heart J; 2006 Sep 06; 152(3):417-9. PubMed ID: 16923406
    [No Abstract] [Full Text] [Related]

  • 18. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J, Müller U.
    MMW Fortschr Med; 2006 Oct 19; 148(42):48. PubMed ID: 17621800
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.